“We are pleased to announce that phase two of upgrading the manufacturing capacity is nearly complete. The final equipment has been fully tested and installed in our Lacey, Washington facility’s production cleanroom.
IntelGenx (IGXT) Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral...
IntelGenx (IGXT) Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films
2020 Elections Create Unique Opportunity for Helix Technologies (HLIX)
In this podcast, Mr. Stanley Teeple discusses the current state of Can B, FDA Products, Brands, and Subsidiaries including their own R&D and production facility.
Can B Corp (CANB) Expands Availability of Insurance Covered Duramed Ultrasound to the Entire State of Michigan
POT reached the $1 million cap in April 2014 but tanked immediately to $244,000 less than a month later. It looked as if it was staying on a downward trend until NBA legend Dennis Rodman wore a PotCoin.com shirt in a North Korean airport. As of January 2020 POT was priced at $0.0056 and is projected to be at $0.60 by the end of 2022.
Cannabics Pharmaceuticals (CNBX) receives "Intention to Grant a European Patent"
In the podcast, Mr. Teeple will discuss the current state of Can B Corp, along with its subsidiaries, new product launches, its FDA approved medical device and its strong medical advisory team.
Miami, FL –October 22, 2020, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for...
Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33